These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9029092)

  • 1. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
    Onodera K; Hancock WW; Graser E; Lehmann M; Sayegh MH; Strom TB; Volk HD; Kupiec-Weglinski JW
    J Immunol; 1997 Feb; 158(4):1572-81. PubMed ID: 9029092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
    J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathymic immunomodulation and the "infectious" tolerance pathway in allograft recipients.
    Reemtsen BL; Kato H; Wang TS; Busuttil RW; Kupiec-Weglinski JW; Goss JA
    J Surg Res; 1999 Jun; 84(1):1-7. PubMed ID: 10334880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients.
    Ke B; Ritter T; Kato H; Zhai Y; Li J; Lehmann M; Busuttil RW; Volk HD; Kupiec-Weglinski JW
    J Immunol; 2000 Jun; 164(11):5739-45. PubMed ID: 10820251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
    Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients.
    Onodera K; Volk HD; Ritter T; Kupiec-Weglinski JW
    J Immunol; 1998 Jun; 160(12):5765-72. PubMed ID: 9637486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance.
    Takeuchi T; Lowry RP; Konieczny B
    Transplantation; 1992 Jun; 53(6):1281-94. PubMed ID: 1351322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts.
    Papp I; Wieder KJ; Sablinski T; O'Connell PJ; Milford EL; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1992 Mar; 148(5):1308-14. PubMed ID: 1347048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
    Kataoka M; Margenthaler JA; Ku G; Eilers M; Flye MW
    Surgery; 2003 Aug; 134(2):227-34. PubMed ID: 12947322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
    Binder J; Hancock WW; Watschinger B; Wasowska B; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1995 Feb; 59(4):590-7. PubMed ID: 7878763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
    Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP
    Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection.
    Semiletova NV; Shen XD; Slomowitz SJ; Baibakov B; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplant Proc; 2005; 37(1):35-6. PubMed ID: 15808538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.